JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB38971

Anti-MMP14 antibody - Hinge region

4

(5 Reviews)

|

(42 Publications)

Rabbit Polyclonal MMP14 antibody. Suitable for WB and reacts with Human samples. Cited in 42 publications. Immunogen corresponding to Synthetic Peptide within Human MMP14.

View Alternative Names

Matrix metalloproteinase-14, MMP-14, MMP-X1, Membrane-type matrix metalloproteinase 1, Membrane-type-1 matrix metalloproteinase, MT-MMP 1, MTMMP1, MT1-MMP, MT1MMP, MMP14

4 Images
Western blot - Anti-MMP14 antibody - Hinge region (AB38971)
  • WB

AbReview18509****

Western blot - Anti-MMP14 antibody - Hinge region (AB38971)

Blocked using 5% milk for 1 hour at 20°C.

All lanes:

Western blot - Anti-MMP14 antibody - Hinge region (ab38971) at 1/5000 dilution

Lane 1:

Whole cell lysate prepared from HT1080 cells at 5 µg

Lane 2:

Whole cell lysate prepared from human vascular smooth muscle cells at 5 µg

Secondary

All lanes:

HRP conjugated donkey anti-rabbit IgG at 1/2000 dilution

Predicted band size: 65 kDa

Observed band size: 20 kDa,63 kDa,65 kDa

true

Exposure time: 30s

This image is a courtesy of an anonymous Abreview

Western blot - Anti-MMP14 antibody - Hinge region (AB38971)
  • WB

Unknown

Western blot - Anti-MMP14 antibody - Hinge region (AB38971)

All lanes:

Western blot - Anti-MMP14 antibody - Hinge region (ab38971)

Lane 1:

Cell lysates from human dermal fibroblasts <i>neonatal</i> (no treatment)

Lane 2:

Cell lysates from human dermal fibroblasts <i>neonatal</i> (treated with II1beta)

Predicted band size: 65 kDa

Observed band size: 66 kDa

false

Western blot - Anti-MMP14 antibody - Hinge region (AB38971)
  • WB

AbReview10483****

Western blot - Anti-MMP14 antibody - Hinge region (AB38971)

All lanes:

Western blot - Anti-MMP14 antibody - Hinge region (ab38971) at 1/1000 dilution

All lanes:

HT1080 whole cell lysate at 30 µg

Secondary

All lanes:

HRP-conjugated donkey anti-rabbit

Predicted band size: 65 kDa

Observed band size: 64 kDa

true

Exposure time: 1min

This image is courtesy of an anonymous Abreview

Western blot - Anti-MMP14 antibody - Hinge region (AB38971)
  • WB

CiteAb

Western blot - Anti-MMP14 antibody - Hinge region (AB38971)

MMP14 western blot using anti-MMP14 antibody - Hinge region ab38971. Publication image and figure legend from Havre, P. A., Dang, L. H., et al., 2013, BMC Cancer, PubMed 24180670.

ab38971 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab38971 please see the product overview.

Erk(1/2) activation is highest in the parental Karpas 299 cell line. Cells (8 x 106) were grown in serum free media for 48 hrs, centrifuged at low speed to remove cells and debris, then at 100,000 x g for 1 hr. Vesicles were suspended in PBS and assayed for protein. Equal amounts of protein (5 μg) were loaded in each well of a 7.5% SDS gel. Following transfer to nitrocellulose, blots were probed with anti-MT1-MMP antibody (top) or anti-phospho-p44/42 MAPK antibody (middle), stripped, and reprobed with anti-p44/42 MAPK antibody (next to bottom). The blot was also probed with anti-α5 integrin antibody (bottom). Data are representative of two independent experiments.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human MMP14. The exact immunogen used to generate this antibody is proprietary information.

P50281

Specificity

This antibody binds to MMP14, but does not cross react with the other MMP family members (MMP1, MMP2, MMP3, MMP9).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/2000 - 1/5000", "WB-species-notes": "<p>When used against the reduced protein this antibody identifies bands at 65 Kd and 63 Kd (the pro-form and active form) as well as activation/breakdown products.</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
Preservative: 0.05% Sodium azide Constituents: 50% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Matrix metalloproteinase 14 (MMP14) also known as MT1-MMP is a membrane-bound enzyme involved in the breakdown of the extracellular matrix. This protease has a molecular weight of approximately 66 kDa and consists of various structural domains including a catalytic domain and a hinge region. MMP14 is expressed in many tissues including the stromal and cancer cells where it facilitates cell migration and tissue remodeling.
Biological function summary

MMP14 influences extracellular matrix degradation enabling cellular invasion and migration. It exists as a part of macromolecular complexes at the cell surface interacting with other metalloproteinases. This interaction assists in the activation of other MMPs such as pro-MMP2 which further amplify matrix remodeling activities. The hinge region of MMP14 lends flexibility allowing it to effectively engage with substrate proteins.

Pathways

MMP14 significantly affects cell signaling and tissue remodeling pathways. One critical pathway involves the activation of pro-MMP2 which is dependent on MMP14's proteolytic activity. MMP14 also plays a role in the regulation of cell proliferation and apoptosis through its interaction with proteins such as TIMP-2. This relationship between MMP14 and other regulatory proteins emphasizes its functional integration within major biological networks.

High MMP14 levels correlate strongly with cancer progression especially in cancers such as breast cancer and melanoma. The ability of MMP14 to degrade the extracellular matrix facilitates tumor invasion and metastasis. Through its regulatory activities MMP14 connects with other proteins like VEGF influencing angiogenesis within tumor microenvironments. Additionally MMP14 involvement in arthritic conditions highlights its role in joint degradation processes worsening the disease through augmented cartilage breakdown.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Endopeptidase that degrades various components of the extracellular matrix such as collagen (PubMed : 8015608). Essential for pericellular collagenolysis and modeling of skeletal and extraskeletal connective tissues during development (By similarity). Activates progelatinase A/MMP2, thereby acting as a positive regulator of cell growth and migration (PubMed : 22065321, PubMed : 8015608). Involved in the formation of the fibrovascular tissues in association with pro-MMP2 (PubMed : 12714657, PubMed : 22065321). May be involved in actin cytoskeleton reorganization by cleaving PTK7 (PubMed : 20837484). Acts as a regulator of Notch signaling by mediating cleavage and inhibition of DLL1 (PubMed : 21572390). Cleaves ADGRB1 to release vasculostatin-40 which inhibits angiogenesis (PubMed : 22330140). Acts as a negative regulator of the GDF15-GFRAL aversive response by mediating cleavage and inactivation of GFRAL (PubMed : 35177851).
See full target information MMP14

Publications (42)

Recent publications for all applications. Explore the full list and refine your search

Journal of clinical medicine 13: PubMed38541774

2024

Paradoxical Changes: EMMPRIN Tissue and Plasma Levels in Marfan Syndrome-Related Thoracic Aortic Aneurysms.

Applications

Unspecified application

Species

Unspecified reactive species

Kyle C Alexander,Carlton W Anderson,Chris B Agala,Panagiotis Tasoudis,Elizabeth N Collins,Yiwen Ding,John W Blackwell,Danielle E Willcox,Behzad S Farivar,Melina R Kibbe,John S Ikonomidis,Adam W Akerman

PloS one 18:e0284875 PubMed37115777

2023

A standardized method for plasma extracellular vesicle isolation and size distribution analysis.

Applications

Unspecified application

Species

Unspecified reactive species

J Nathaniel Diehl,Amelia Ray,Lauren B Collins,Andrew Peterson,Kyle C Alexander,Jacob G Boutros,John S Ikonomidis,Adam W Akerman

Bone reports 16:101590 PubMed35663377

2022

Temporal changes in cortical microporosity during estrogen deficiency associated with perilacunar resorption and osteocyte apoptosis: A pilot study.

Applications

Unspecified application

Species

Unspecified reactive species

H Allison,L M O'Sullivan,L M McNamara

PloS one 17:e0262479 PubMed35015787

2022

Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.

Applications

Unspecified application

Species

Unspecified reactive species

Yuhua Zhang,An O Van Laer,Catalin F Baicu,Lily S Neff,Stanley Hoffman,Marc R Katz,Sanford M Zeigler,Michael R Zile,Amy D Bradshaw

Communications biology 4:1091 PubMed34531530

2021

TC10 regulates breast cancer invasion and metastasis by controlling membrane type-1 matrix metalloproteinase at invadopodia.

Applications

Unspecified application

Species

Unspecified reactive species

Maren Hülsemann,Colline Sanchez,Polina V Verkhusha,Vera Des Marais,Serena P H Mao,Sara K Donnelly,Jeffrey E Segall,Louis Hodgson

Biomolecules 11: PubMed33396696

2020

AG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an Increase in MMP-2 Secretion and MT1-MMP Expression, in a RPSA-Dependent Manner.

Applications

Unspecified application

Species

Unspecified reactive species

Clara Bretaudeau,Stéphanie Baud,Aurélie Dupont-Deshorgue,Rémi Cousin,Bertrand Brassart,Sylvie Brassart-Pasco

Methods in molecular biology (Clifton, N.J.) 2230:303-323 PubMed33197021

2020

Assessment of Osteocytes: Techniques for Studying Morphological and Molecular Changes Associated with Perilacunar/Canalicular Remodeling of the Bone Matrix.

Applications

Unspecified application

Species

Unspecified reactive species

Neha S Dole,Cristal S Yee,Charles A Schurman,Sarah L Dallas,Tamara Alliston

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 35:196-210 PubMed31610061

2019

YAP and TAZ Mediate Osteocyte Perilacunar/Canalicular Remodeling.

Applications

Unspecified application

Species

Unspecified reactive species

Christopher D Kegelman,Jennifer C Coulombe,Kelsey M Jordan,Daniel J Horan,Ling Qin,Alexander G Robling,Virginia L Ferguson,Teresita M Bellido,Joel D Boerckel

Cells 8: PubMed31466384

2019

Endoglin Trafficking/Exosomal Targeting in Liver Cells Depends on -Glycosylation.

Applications

Unspecified application

Species

Unspecified reactive species

Steffen Meurer,Almut Elisabeth Wimmer,Eddy van de Leur,Ralf Weiskirchen

Molecular therapy. Nucleic acids 16:229-245 PubMed30925451

2019

Bone Marrow Mesenchymal Stem Cell-Derived Exosomal MicroRNA-126-3p Inhibits Pancreatic Cancer Development by Targeting ADAM9.

Applications

Unspecified application

Species

Unspecified reactive species

Dong-Mei Wu,Xin Wen,Xin-Rui Han,Shan Wang,Yong-Jian Wang,Min Shen,Shao-Hua Fan,Zi-Feng Zhang,Qun Shan,Meng-Qiu Li,Bin Hu,Jun Lu,Gui-Quan Chen,Yuan-Lin Zheng
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com